AllAnalyst Report
logoMorningstarMay 18, 2021

Charles River Laboratories International, Inc.: Charles River to Acquire Vigene Biosciences, Expanding Gene Therapy Capabilities; Maintain $170 FVE

Symbols
CRL
Sector(s)
Healthcare
Rating
Current Price
$357.78
Fair Value
Economic Moat
Stewardship
Summary

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free